Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin

Total article views   Abstract views HTML views PDF downloads Totals
8,486 Dovepress* 5,954 1,032+ 1,327 6,986
PubMed Central* 0 1,500 546 1,500
Totals 5,954 2,532 1,873 8,486
*Since 3 May 2017
+Since July 2016

View citations on PubMed Central and Google Scholar